Showing 2,681 - 2,700 results of 4,404 for search '"Clinical trial"', query time: 0.08s Refine Results
  1. 2681

    Passive Monitoring of Parkinson Tremor in Daily Life: A Prototypical Network Approach by Luc J. W. Evers, Yordan P. Raykov, Tom M. Heskes, Jesse H. Krijthe, Bastiaan R. Bloem, Max A. Little

    Published 2025-01-01
    “…Objective and continuous monitoring of Parkinson’s disease (PD) tremor in free-living conditions could benefit both individual patient care and clinical trials, by overcoming the snapshot nature of clinical assessments. …”
    Get full text
    Article
  2. 2682
  3. 2683

    Promising role of voxelotor in managing sickle cell disease in children: a narrative review by Amit Agrawal, Gaurav Jadon, Japna Singh, Dalwinder Janjua

    Published 2025-02-01
    “…The group that received voxelotor also showed a greater decrease in hemolytic markers but a comparable incidence of side effects. Six ongoing clinical trials also sought to ascertain the effectiveness and safety of high-dose voxelotor when administered to children younger than 12 years. …”
    Get full text
    Article
  4. 2684

    Asbestos Induces Reduction of Tumor Immunity by Naoko Kumagai-Takei, Megumi Maeda, Ying Chen, Hidenori Matsuzaki, Suni Lee, Yasumitsu Nishimura, Junichi Hiratsuka, Takemi Otsuki

    Published 2011-01-01
    “…However, regarding bad prognosis of mesothelioma, medical approaches to ensure the recognition of the biological effects of asbestos and the pathological mechanisms of asbestos-induced carcinogenesis, as well as clinical trials to detect the early stage of mesothelioma, should result in better preventions and the cure of these malignancies. …”
    Get full text
    Article
  5. 2685

    Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review by Jawaher Ansari, Muhammad Ali, Ashraf Farrag, Arwa M. Ali, Abdulaziz Alhamad

    Published 2018-01-01
    “…Treatment of patients with metastatic renal cell carcinoma (mRCC) and end-stage renal disease (ESRD) on dialysis poses a therapeutic challenge, particularly as this patient group was excluded from the pivotal clinical trials. In addition, there is uncertainty regarding drug dosing/pharmacokinetics, lack of safety and efficacy data, and potential for increased toxicity when using targeted therapy or immunotherapy for the management of patients with mRCC on dialysis. …”
    Get full text
    Article
  6. 2686

    Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review by Carrie A. Forman, Shari R. Lipner

    Published 2025-01-01
    “…Conclusion: Many biologics and small molecules are effective in treating nail psoriasis and alopecia areata, with each requiring precautions for adverse events. Clinical trials for use of biologics and small molecules for nail lichen planus and atopic dermatitis have not been published to date.…”
    Get full text
    Article
  7. 2687

    Sulforaphane as a preventive agent in Oral Cancer- A Systematic Review by M. Parasakthi, Kavitha Sanjeev

    Published 2024-06-01
    “…Conclusion: Based on the analysis of studies included in this systematic review, sulforaphane is found to be effective in prevention of oral cancer. But further clinical trials are necessary to assess the effects of sulforaphane on oral cancer patients.…”
    Get full text
    Article
  8. 2688
  9. 2689

    Brain-targeting drug delivery systems: The state of the art in treatment of glioblastoma by Bo Sun, Rong Li, Ning Ji, Han Liu, Hongxiang Wang, Chao Chen, Long Bai, Jiacan Su, Juxiang Chen

    Published 2025-02-01
    “…This emphasis has driven the exploration and evaluation of diverse technologies for GBM pharmacotherapy, with some already undergoing clinical trials. This review provides a thorough overview of recent advancements and challenges in targeted drug delivery for GBM treatment. …”
    Get full text
    Article
  10. 2690

    Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects by Dileep G. Nair, Ralf Weiskirchen

    Published 2024-12-01
    “…Differences in physiology between humans and animals or cell lines contribute to the failure of many drug programs during clinical trials. The use of advanced in vitro systems that closely mimic human physiology, such as organ-on-a-chip models like gut–liver-on-a-chip, can be crucial in improving drug efficacy while minimizing toxicity. …”
    Get full text
    Article
  11. 2691

    Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancer by Brock J. Sishc, Janapriya Saha, Elizabeth M. Alves, Lianghao Ding, Huiming Lu, Shih-Ya Wang, Katy L. Swancutt, James H. Nicholson, Angelica Facoetti, Arnold Pompos, Mario Ciocca, Todd A. Aguilera, Michael D. Story, Anthony J. Davis

    Published 2025-01-01
    “…Abstract Pancreatic ductal adenocarcinoma (PDAC) is notably resistant to conventional chemotherapy and radiation treatment. However, clinical trials indicate that carbon ion radiotherapy (CIRT) with concurrent gemcitabine is effective for unresectable locally advanced PDAC. …”
    Get full text
    Article
  12. 2692

    Lipopeptide adjuvants for antibiotics and vaccines: the future step in the fight against multidrug-resistant and extensively drug-resistant pathogens by Chloé O. Sebilleau, Steven J. Sucheck

    Published 2024-04-01
    “…Findings discussed in this review could be applied to the development of safer, more effective adjuvants, that could expand the use or repurpose current antibiotics or improve vaccination results in future clinical trials.…”
    Get full text
    Article
  13. 2693

    Efficacy of different preoperative antiseptics in preventing a risk of surgical site infections: a systematic review and meta‑analysis of randomized controlled trials by Lutao Yang, Shunxin Liao, Qing Cao, Sanjay Rastogi

    Published 2024-07-01
    “…Results: This meta-analysis included 10 587 surgical patients from 18 randomized clinical trials to determine the effectiveness of chlorhexidine in alcohol (CHA; 0.5%, 2%–2.5%, and 4%) with aqueous or alcoholic iodine in preventing postoperative SSIs. …”
    Get full text
    Article
  14. 2694

    Extended Peritoneal Dialysis and Renal Recovery in HIV-Infected Patients with Prolonged AKI: A Report of 2 Cases by Donlawat Saengpanit, Pongpratch Puapatanakul, Piyaporn Towannang, Talerngsak Kanjanabuch

    Published 2017-01-01
    “…Its efficacy in providing fluid and small solute removal has also been demonstrated in clinical trials and is equivalent to hemodialysis (HD). …”
    Get full text
    Article
  15. 2695

    Brain-Derived Neurotrophic Factor and Nerve Growth Factor Therapeutics for Brain Injury: The Current Translational Challenges in Preclinical and Clinical Research by Serena-Kaye Sims, Brynna Wilken-Resman, Crystal J. Smith, Ashley Mitchell, Lilly McGonegal, Catrina Sims-Robinson

    Published 2022-01-01
    “…However, the translation of these studies into clinical trials has been limited. Preclinical experiments have largely failed to result in significant impacts in clinical research. …”
    Get full text
    Article
  16. 2696

    Baseline shock index and baroreflex function in older adults by Kenneth M. Madden, Boris Feldman, Graydon S. Meneilly

    Published 2025-03-01
    “…Autonomic dysfunction is associated with lower SI in older adults, potentially masking circulatory instability.ClinicalTrials.gov ID NCT01914133…”
    Get full text
    Article
  17. 2697

    The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases by Pål-Dag Line, Morten Hagness, Svein Dueland

    Published 2018-01-01
    “…There is an increasing interest in liver transplantation in these patients in the transplant community, and currently 4 clinical trials are active and are recruiting.…”
    Get full text
    Article
  18. 2698

    Results comparison of cervical cancer early detection using cerviray ® with VIA test by Ali Budi Harsono, Hadi Susiarno, Dodi Suardi, Kemala Isnainiasih Mantilidewi, Viko Duvadilan Wibowo, Yudi Mulyana Hidayat

    Published 2025-01-01
    “…Trial registration Clinical Trials.gov Identifier NCT06518070 Retrospectively registered.…”
    Get full text
    Article
  19. 2699

    Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature Review by Erin K. Yeung, Haritha Saikumar, Jose Castaneda-Nerio, Sandra G. Adams, Mark Wong

    Published 2018-01-01
    “…The suggested benefit of icatibant in intubated ACEI-induced angioedema patients should be verified by randomized clinical trials and cost-benefit analyses should be performed at individual institutions.…”
    Get full text
    Article
  20. 2700

    Transformative advancements in immune checkpoint inhibitor therapy for Oropharyngeal Squamous Cell Carcinoma (OPSCC) by Iadalin Ryntathiang, Mukesh Kumar Dharmalingam Jothinathan

    Published 2024-09-01
    “…Furthermore, current clinical trials are exploring innovative combinations of ICIs and treatment sequences in order to enhance patient outcomes. …”
    Get full text
    Article